Note 13 - Noncontrolling Interest - Schedule of Noncontrolling Interest (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| NCI – equity - December 31, 2025 | $ 24,988 | $ 38,932 | $ 22,300 | $ (7,033) |
| Net loss attributable to NCI | (6,598) | (12,324) | (7,662) | 6,300 |
| Impact of subsidiary equity transactions | 0 | 0 | 0 | |
| Stock-based compensation expense | 8 | 7 | 16 | 300 |
| NCI – equity – June 30, 2026 | 19,307 | 28,159 | 19,307 | 28,159 |
| Noncontrolling Interest [Member] | ||||
| NCI – equity - December 31, 2025 | (14,535) | (6,062) | (11,667) | (4,538) |
| Net loss attributable to NCI | (2,218) | |||
| Impact of subsidiary equity transactions | (5,507) | (1,872) | (7,928) | |
| Stock-based compensation expense | 8 | 7 | 16 | 300 |
| NCI – equity – June 30, 2026 | $ (15,741) | $ (9,371) | (15,741) | $ (9,371) |
| Noncontrolling Interest [Member] | Veris Health [Member] | ||||
| Stock-based compensation expense | $ 16 | |||
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under subsidiary share-based payment arrangement. No definition available.
|
| X | ||||||||||
- Definition Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|